EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Role of THBS4 in Chronic Kidney Disease Fibrosis: From Clinical Observations to Molecular Mechanisms

Xu Yan, Kun Zhao, Ye Yao, Lihui Wang, Wei Shan, Yan Zhang

Frontiers in Bioscience-Landmark · 2025

DOI: 10.31083/fbl26076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2025. Verfasst von Xu Yan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The Second Affiliated Hospital of Qiqihar Medical University, 161006 Qiqihar, Heilongjiang, China. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Thrombospondins, Kidney. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Commission of Heilongjiang Province Scientific Research Topics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic kidney disease (CKD), driven by progressive renal fibrosis, lacks effective therapeutic targets. This study investigates thrombospondin-4 (THBS4) as a novel mediator of CKD-related fibrosis and explores its mechanistic basis.

Methods

This study collected 100 patients diagnosed with chronic kidney disease and 30 healthy individuals. Enzyme-linked immunosorbent assay (ELISA) analysis was conducted to assess the expression of THBS4 in CKD patients. Mouse unilateral ureteral obstruction (UUO) renal fibrosis model and Human Kidney-2 (HK2) cell fibrosis model were constructed to analyze the expression changes of THBS4 in renal fibrosis. To examine the effects of inhibiting THBS4 expression on the process of renal fibrosis, these two models were analyzed using Sirius red staining, Masson staining, immunohistochemistry, real-time quantitative PCR (qPCR) and western blot methods.

Results

The expression of THBS4 in the serum of CKD patients was found to be significantly higher (p < 0.05), and its concentration showed a negative correlation with the eGFR levels (r = –0.77, p < 0.05) and an increase corresponding to the progression of CKD stages (p < 0.05). THBS4 expression was dramatically increased in UUO-treated mouse kidneys as well as in TGF-β1-stimulated HK2 cells (p < 0.05). In vitro, the expression of renal fibrosis-associated proteins was also significantly reduced after interfering with THBS4 expression (p < 0.05). UUO-induced renal fibrosis and related protein expression were suppressed in THBS4 knockdown mice when compared to control mice (p < 0.05). The levels of p-AKT and p-PI3K exhibited a significant rise in conjunction with the onset of renal fibrosis (p < 0.05). The expression of p-AKT as well as p-PI3K showed a significant reduction upon inhibition of THBS4 expression (p < 0.05). Insulin-like growth factor 1 (IGF-1) treatment reversed these effects.

Conclusion

THBS4 was significantly overexpressed in CKD patients. By suppressing the expression of proteins associated with renal fibrosis and inhibiting the activation of the PI3K/AKT pathway, THBS4 has the potential to mitigate renal fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicThrombospondinsKidneyHumansAnimalsFibrosisMiceMaleFemaleMiddle AgedCell LineDisease Models, AnimalSignal TransductionUreteral ObstructionMice, Inbred C57BLAgedAdultProto-Oncogene Proteins c-akt

Stichwörter der Autor:innen

PI3K/AKT pathwaychronic kidney diseasefibrosis-associated proteinrenal fibrosisthrombospondin-4

Substanzen

Thrombospondinsthrombospondin 4Proto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Department of Nephrology, The Second Affiliated Hospital of Qiqihar Medical University, 161006 Qiqihar, Heilongjiang, China.
  • College of Basic Medical Sciences, Qiqihar Medical University, 161006 Qiqihar, Heilongjiang, China.
  • Department of Laboratory Medicine, The Second Affiliated Hospital of Qiqihar Medical University, 161006 Qiqihar, Heilongjiang, China.

Förderung

  • Health Commission of Heilongjiang Province Scientific Research Topics

Zitieren

APA

Yan, X., Zhao, K., Yao, Y., Wang, L., Shan, W., & Zhang, Y. (2025). The Role of THBS4 in Chronic Kidney Disease Fibrosis: From Clinical Observations to Molecular Mechanisms. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl26076

Vancouver

Yan X, Zhao K, Yao Y, Wang L, Shan W, Zhang Y. The Role of THBS4 in Chronic Kidney Disease Fibrosis: From Clinical Observations to Molecular Mechanisms. Frontiers in Bioscience-Landmark. 2025. doi:10.31083/fbl26076

BibTeX
@article{Yan2025,
  author = {Yan, Xu and Zhao, Kun and Yao, Ye and Wang, Lihui and Shan, Wei and Zhang, Yan},
  title = {The Role of THBS4 in Chronic Kidney Disease Fibrosis: From Clinical Observations to Molecular Mechanisms},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2025},
  doi = {10.31083/fbl26076}
}
Kostenlos starten →